MusclePharm Makes Strategic Investment in Fuse Science, Inc.

DENVER, CO--(Marketwired - Nov 8, 2013) - MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm"), a leading international, award-winning sports nutrition company, announced today it has made a strategic investment in Fuse Science, Inc. (OTCQB: DROP) ("Fuse").

MusclePharm's investment was part of a larger investment from several other prominent investors, many of whom also participated in MusclePharm's $12 million registered direct public offering in early 2013. MusclePharm's financial interest is part of on-going discussions that may lead to a more meaningful strategic relationship between MusclePharm and Fuse Science®.

Fuse Science, Inc. is an innovative consumer products and delivery technology company based in Miami Lakes, Florida. Fuse Science® holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. Fuse Science® maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly -- all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science® technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science® is available online at www.fusescience.com and www.poweredbyfuse.com.

"The investment in Fuse emanates from our interest in its delivery technology and products," stated Brad Pyatt, Founder and CEO of MusclePharm. "It is aligned with our strategy of leveraging our marketing and distribution channels while bringing both innovation and sophistication to the sport nutrition market. We look forward to continuing ongoing discussions with the Fuse management team and exploring various possibilities for a mutually advantageous strategic relationship."

ABOUT MUSCLEPHARM CORPORATION

MusclePharm® is a leading international, award-winning sports nutrition company offering vitamins and nutritional supplements which are available in more than 110 countries and available in 15,000+ U.S. retail outlets, including Costco, Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC, Vitamin Shoppe and Vitamin World. The company's brands are MusclePharm®, Arnold Schwarzenegger Series™, and FitMiss™. The comprehensive lines of clinically-proven, safe and effective nutritional supplements are developed through a six-stage research process that utilizes the expertise of leading nutritional scientists, doctors and universities. For more information, visit www.musclepharmcorp.com. Follow the company at http://www.facebook.com/MusclePharm and www.Twitter.com/MusclePharm.

FORWARD-LOOKING STATEMENTS

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.